Rothschild Asset Management Inc. Sells 190 Shares of Stryker Corporation (SYK)
Rothschild Asset Management Inc. lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 5.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,398 shares of the medical technology company’s stock after selling 190 shares during the period. Rothschild Asset Management Inc.’s holdings in Stryker Corporation were worth $472,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of SYK. Bollard Group LLC raised its position in Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares in the last quarter. Baystate Wealth Management LLC raised its position in Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares in the last quarter. James Investment Research Inc. purchased a new position in Stryker Corporation during the second quarter worth approximately $155,000. Guardian Life Insurance Co. of America raised its position in Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares in the last quarter. Finally, Assetmark Inc. raised its position in Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares in the last quarter. 74.16% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Stryker Corporation (NYSE:SYK) opened at 139.33 on Thursday. The firm has a market cap of $52.12 billion, a P/E ratio of 31.10 and a beta of 0.80. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $148.84. The firm’s 50-day moving average is $144.80 and its 200-day moving average is $137.03.
Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. During the same period in the previous year, the company posted $1.39 EPS. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. On average, analysts anticipate that Stryker Corporation will post $6.47 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.22%. Stryker Corporation’s payout ratio is 37.95%.
ILLEGAL ACTIVITY WARNING: “Rothschild Asset Management Inc. Sells 190 Shares of Stryker Corporation (SYK)” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/rothschild-asset-management-inc-sells-190-shares-of-stryker-corporation-syk/1532980.html.
SYK has been the topic of a number of recent analyst reports. BMO Capital Markets reissued a “hold” rating and issued a $140.00 price target on shares of Stryker Corporation in a research report on Tuesday, July 11th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Stryker Corporation in a research report on Monday, June 19th. Citigroup Inc. lifted their price target on shares of Stryker Corporation from $114.00 to $125.00 and gave the company a “sell” rating in a research report on Friday, June 9th. Cantor Fitzgerald initiated coverage on shares of Stryker Corporation in a research report on Thursday, June 29th. They issued a “neutral” rating and a $153.00 price target on the stock. Finally, Morgan Stanley reissued an “overweight” rating and issued a $160.00 price target (up previously from $155.00) on shares of Stryker Corporation in a research report on Monday, July 10th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $145.73.
In related news, insider David Floyd sold 19,305 shares of the business’s stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total transaction of $2,790,730.80. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now owns 88,207 shares in the company, valued at $12,909,976.52. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,810 shares of company stock worth $4,754,958. 7.40% of the stock is currently owned by corporate insiders.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.